Development of non-invasive transdermal patch of Emblica officinalis for anti atherosclerotic activity

Nakuleshwar Dut Jasuja, Parduman Raj Sharma, Sunita Jain, Suresh C Joshi


The present study was designed to formulate matrix type transdermal patches of a potent anti atherosclerotic botanical Emblica officinalis on a mercury substrate and evaluated for physicochemical parameters like thickness, % flatness, weight variation, moisture uptake, moisture content, folding endurance, elongation and drug content values. Further, in vivo drug release was also observed by HPLC in rabbit serum. Four formulations were prepared using different ratio of matrix forming polymers, plasticizer and penetration enhancers. Formulations E-1, E-2, E-3 and E-4 were composed of Ethyl cellulose (EC) and Hydroxypropyl Methylcellulose (HPMC) with the following ratios: 6:4, 7:3, 8:2 and 9:1. In vitro cumulative amounts of the permeated drug were observed 48.53, 55.46, 73.26 and 99.72% in 48 hrs from the four formulations. The release profile of the optimized formulation E-4; r2 = 0.984 (Higuchi) showed that permeation of the drug controlled by a diffusion mechanism. The cumulative amount of the permeated drug after 48hrs from E-4 was 343.95mcg/cm2. Permeability coefficient was calculated 7.16mcg/cm2/hr. Based on physicochemical and in vitro skin permeation studies, E-4 was chosen for further in vivo studies. Blood plasma concentration of E-4 after 48 hrs was 0.2914mcg/cm2. Skin permeation performance and scanning electron microscopic studies revealed that formulation E-4 was found to be better than other formulations and it was selected as the optimized formulation. The skin irritation tests showed negligible erythema and edema. The developed transdermal patches may increase the efficacy of E. officinalis for the therapy of atherosclerosis.


Transdermal; polymers; permeation; atherosclerosis

Full Text:



. Pang GKH, Qiao D. Transdermal drug delivery models. J Biomedical Science and Engineering 2010; 3:367-374.

. Anitha P, Ramkanth S, Uma Sankari K, Alagusundaram M, Gnanapraksah K, Devaki Devi P, Indira Prasanna R. Ethosomes - A noninvasive vesicular carrier for transdermal drug delivery. Int J Rev Life Sci. 2011;1(1):17-24.

. Chien YW. Transdermal therapeutic system. In: Robinson JR, Lee VHL, eds. Controlled Drug Delivery Fundamentals and Applications. 2nd ed. New York, NY: Marcel Dekker, 1987. 524-552.

. Joshi SC, Jasuja ND, Jain S. Enhancement of Transdermal Delivery System and Antidiabetic approach: An overview. Int J Pharm. 2012; 2 (1):129-141.

. Pareek H, Sharma S, Khajja BS, Jain K, Jain GC. Evaluation of hypoglycemic and anti-hyperglycemic potential of Tridax procumbens (Linn.). BMC Complementary and Alternative Medicine 2009; 9:1-7.

. Patel NA, Patel NJ, Patel RP. Design and evaluation of transdermal drug delivery system for curcumin as an anti-inflammatory drug. Drug Dev Ind Pharm. 2009; 35(2):234-242.

. Jasuja ND, Choudhary J, Sharama P, Sharma N, Joshi SC. A review on bioactive compounds and medicinal uses of Commiphora mukul. J Plan Sci. 2012; 7: 113-137.

. Kumar K, Rai AK. Miraculous therapeutic effects of herbal drugs using novel drug delivery systems. IRJP. 2012; 3(2):27-30.

. Jain S, Joshi SC. Development of transdermal matrix system of captopril based on cellulose derivative. Pharmacolgyonline 2007a; 1:379-390.

. Jain S, Joshi SC. Transdermal delivery of propanol hydrochloride through matrices of combined cellulose derivatives. Pharmacologyonline 2007b; 3:518-544.

. Devi VK, Jain N, Valli KS. Importance of novel drug delivery systems in herbal medicines. Phcog Rev. 2010; 4(7):27-31.

. Goyal A, Kumar S, Nagpal M, Singh I, Arora S. Potential of Novel Drug Delivery Systems for Herbal Drugs. Ind J Pharm Edu Res. 2011; 45(3):225-235.

. Scartezzini P, Antognoni F, Raggi MA, Poli F, Sabbioni C. Vitamin C content and antioxidant activity of the fruit and of the Ayurvedic preparation of Emblica officinalis Gaertn. J Ethnopharmacol. 2006; 104(1-2):113-118.

. Scartezzini P, Speroni E. Review on some plants of Indian traditional medicine with antioxidant activity. J Ethnopharmacol. 2000; 71(1-2):23-43.

. Jose JK, Kuttan R. Antioxidant activity of Emblica officinalis. J Clin Biochem Nutr. 1995; 19:63-70.

. Munden BJ, Dekay HG, Banker GS. Evaluation of polymeric materials Iscreening of film coating agents. J Pharm Sci. 1964; 53(4):395-401.

. Langer R. Transdermal Drug Delivery: past progress, current status, and future prospects. Advanced Drug Delivery Reviews. 2004; 56(5):557-558.

. Amnuaikit C, Ikeuchi I, Ogawara K, Higaki K, Kimura T. Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use. Int J Pharm. 2005; 289:167-178.

. Saxena M, Mutalik S, Reddy MS. Formulation and evaluation of transdermal patches of metoclopramide hydrochloride. Ind Drugs. 2006; 43:740-745.

. Devi VK, Saisivam S, Maria GR, Deepti PU. Design and evaluation of matrix diffusion controlled transdermal patches of verapamil hydrochloride. Drug Dev Ind Pharm. 2003; 29(5):495-503.

. Arora P, Mukherjee B. Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containg diclofenac diethylammonium salt. J Pharm Sci. 2002; 91(9):2076-2089.

. Danjo K, Nishio F, Zhow BD, Otsuka A. Interactions between water and pharmaceutical polymers determined by water-vapor sorption measurement and differential scanning calorimetry. Chem Pharm Bull. 1995; 43(11):1958-1960.

. Draize JH, Woodward GS, Calvery HO. Method for the study of irritation and toxicity of substances applied topically to the skin and mucus membrane. J Pharmacol Exp Ther. 1944; 82:377-390.

. Williams A. In: Transdermal and Topical Drug Delivery. Published by the Pharmaceutical Press. London, 2004; 62.

. Sutariya V, Mashru R, Sunkalia MS. Transbuccal delivery of lomotrigine across procine buccal mucosa invitro determination of roots of buccal transport. J Pharm Sci. 2005; 8:54-62.

. Venkateswarlu V, Thomas SKN, Sreekanth J. Development of Transdermal Drug Delivery Systems with Natural Polymer from Salacia macrosperma. Indian Drugs. 2000; 37(9):407-411.

. Udupa N, Pandey N, Praveen SH. Formulation and evaluation of Nimesulide transdermal drug delivery systems. Indian J Pharm Sci. 2000; 62(5):376-379.

. Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001; 13:123-133.

. Amarowicz R, Weidner S. Content of phenolic acids in rye caryopses determined using HPLC-DAD method. Czech J Food Sci. 2001;19(6):201-203.

. Muhammed M, Bhat B, Jadhav AN, Srivastava JS, Nagabhushanam K. Ascorbic Acid and Tannins from Emblica officinalis Gaertn. Fruitss: A Revisit. J Agric Food Chem. 2009; 57 (1):220-225.

. Andega S, Kanikkannan N, Singh M. Comparison of the effect of fatty alcohols on the permeation of melatonin between porcine and human skin. J Control Release. 2001; 77 (1-2):17-25.

. Nolan LM, Corish J, Corrigan OI, Fitzpatrick D. Iontophoretic and chemical enhancement of drug delivery. Part I: across artificial membranes. Int J Pharm. 2003; 257(1-2):41-55.

. Mahmoud E, Gihan F, Mohamed F. Improvement of solubility and dissolution rate of indomethacin by solid dispersions in Gelucire 50/13 and PEG4000. Saudi Pharmaceutical Journal. 2009; 17:217–225.

. Manosroi A, Kongkaneramit L, Manosroi J. Characterization of amphotericin B liposome formulations. Drug Dev Ind Pharm. 2004; 30:535-543.

. Mosquera MJ, Cal S, Souto S. Effects of Storage humidity on the mechanical, microstructural and propylcellulose based hydrophilic matrix tablets. Drug Dev Ind Pharm. 1997; 23(4):403-406.

. Sadeghi F, Ford JL, Rubinstein MH, Rajabi-Siahboomi AR. Study of drug release from pellets coated with Surelease containing hydroxypropylmethylcellulose. Drug development and industrial pharmacy. 2001; 27(5):419-430.



  • There are currently no refbacks.


Advanced Research Journals

4/70-71. Black Well HB, ALW 301001 IND

Copyright@authors 2009-2016


Follow @arjournals on Twitter